In colorectal cancer, elevated TPD52 expression independently predicts poor survival and is associated with advanced tumor stage, metastasis, and enhanced invasiveness via Focal adhesion kinase (FAK)/integrin and PI3K/AKT-mediated EMT activation, positioning it as a potential therapeutic target [40]. This evidence concerns the gene TPD52 and colorectal cancer.